Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1991 1
1993 1
1994 2
1995 3
1998 1
1999 1
2000 2
2001 2
2002 1
2003 2
2004 1
2005 1
2007 1
2008 3
2009 3
2013 2
2014 7
2015 5
2016 2
2017 3
2018 4
2019 10
2020 6
2021 4
2022 7
2023 7
2024 1

Text availability

Article attribute

Article type

Publication date

Search Results

68 results

Results by year

Filters applied: . Clear all
Page 1
Showing results for martin garcia months
Search for Martin Garcia-Montes instead (1 results)
Polypill Strategy in Secondary Cardiovascular Prevention.
Castellano JM, Pocock SJ, Bhatt DL, Quesada AJ, Owen R, Fernandez-Ortiz A, Sanchez PL, Marin Ortuño F, Vazquez Rodriguez JM, Domingo-Fernández A, Lozano I, Roncaglioni MC, Baviera M, Foresta A, Ojeda-Fernandez L, Colivicchi F, Di Fusco SA, Doehner W, Meyer A, Schiele F, Ecarnot F, Linhart A, Lubanda JC, Barczi G, Merkely B, Ponikowski P, Kasprzak M, Fernandez Alvira JM, Andres V, Bueno H, Collier T, Van de Werf F, Perel P, Rodriguez-Manero M, Alonso Garcia A, Proietti M, Schoos MM, Simon T, Fernandez Ferro J, Lopez N, Beghi E, Bejot Y, Vivas D, Cordero A, Ibañez B, Fuster V; SECURE Investigators. Castellano JM, et al. N Engl J Med. 2022 Sep 15;387(11):967-977. doi: 10.1056/NEJMoa2208275. Epub 2022 Aug 26. N Engl J Med. 2022. PMID: 36018037 Clinical Trial.
METHODS: In this phase 3, randomized, controlled clinical trial, we assigned patients with myocardial infarction within the previous 6 months to a polypill-based strategy or usual care. The polypill treatment consisted of aspirin (100 mg), ramipril (2.5, 5, or 10 mg), and …
METHODS: In this phase 3, randomized, controlled clinical trial, we assigned patients with myocardial infarction within the previous 6 mo …
Granular parakeratosis.
Martín-García RF, Muñoz CM, Montalvo L. Martín-García RF, et al. Bol Asoc Med P R. 2003 Jul-Aug;95(4):43-6. Bol Asoc Med P R. 2003. PMID: 15032029 Review.
This is a report of a 60 year-old black female patient presenting with pruritic brownish crusted plaques on both axillae of one month evolution. Histopathology revealed findings characteristic of axillary granular parakeratosis. ...
This is a report of a 60 year-old black female patient presenting with pruritic brownish crusted plaques on both axillae of one month …
Report of two sisters with Netherton syndrome successfully treated with dupilumab and review of the literature.
Martin-García C, Godoy E, Cabrera A, Cañueto J, Muñoz-Bellido FJ, Perez-Pazos J, Dávila I. Martin-García C, et al. Int J Immunopathol Pharmacol. 2023 Jan-Dec;37:3946320231172881. doi: 10.1177/03946320231172881. Int J Immunopathol Pharmacol. 2023. PMID: 37200480 Free PMC article. Review.
All scores were reduced after 16 weeks of treatment with dupilumab in both patients. She maintains improvement after 18 months and 12 months of treatment, respectively. No severe adverse events were reported. ...
All scores were reduced after 16 weeks of treatment with dupilumab in both patients. She maintains improvement after 18 months and 12 …
Failure of Biologic Therapy in Psoriasis.
Cardona R, Pelet Del Toro NM, Michelen-Gómez E, Arias-Berrios GE, Martín-García RF. Cardona R, et al. Among authors: martin garcia rf. P R Health Sci J. 2021 Jun;40(2):63-67. P R Health Sci J. 2021. PMID: 34543563
The biologic with the longest mean duration of use prior to its discontinuation was UST (17.0 months), followed by ADA (15.9 months) and ETA (13.6 months). CONCLUSION: The most common reason for discontinuing biologic therapy was that said therapy was not eff …
The biologic with the longest mean duration of use prior to its discontinuation was UST (17.0 months), followed by ADA (15.9 month …
Cardiovascular toxicity of checkpoint inhibitors: review of associated toxicity and design of the Spanish Immunotherapy Registry of Cardiovascular Toxicity.
Zatarain-Nicolás E, Martín P, Márquez Rodas I, Virizuela J, Martín García A, Mitroi C, Cosín Sales J, Barrios V, Sánchez-Cabo F, Ibañez B, de Castro Carpeño J, López Fernández T. Zatarain-Nicolás E, et al. Among authors: martin garcia a. Clin Transl Oncol. 2023 Nov;25(11):3073-3085. doi: 10.1007/s12094-023-03217-2. Epub 2023 May 25. Clin Transl Oncol. 2023. PMID: 37227656 Review.
An exhaustive prospective cardiac imaging study will be performed before and during the first 12 months of treatment. The correlation between clinical, imaging, and immunologic parameters may improve our understanding of ICI-induced cardiotoxicity and enable simpler survei …
An exhaustive prospective cardiac imaging study will be performed before and during the first 12 months of treatment. The correlation …
COVID-19 mRNA Vaccines Preserve Immunogenicity after Re-Freezing.
Grau S, Martín-García E, Ferrández O, Martín R, Tejedor-Vaquero S, Gimeno R, Magri G, Maldonado R. Grau S, et al. Among authors: martin garcia e. Vaccines (Basel). 2022 Apr 12;10(4):594. doi: 10.3390/vaccines10040594. Vaccines (Basel). 2022. PMID: 35455343 Free PMC article.
We reveal that the mRNA integrity of Comirnaty() and Spikevax() vaccines remained unaffected after re-freezing during 1 month at -20 C or -80 C. The immunological responses also remained unchanged in mice after these re-freezing conditions and no apparent side effects were …
We reveal that the mRNA integrity of Comirnaty() and Spikevax() vaccines remained unaffected after re-freezing during 1 month at -20 …
Platelet-rich plasma for thumb carpometacarpal joint osteoarthritis in a professional pianist: case-based review.
Medina-Porqueres I, Martin-Garcia P, Sanz-De Diego S, Reyes-Eldblom M, Cantero-Tellez R. Medina-Porqueres I, et al. Among authors: martin garcia p. Rheumatol Int. 2019 Dec;39(12):2167-2175. doi: 10.1007/s00296-019-04454-x. Epub 2019 Oct 14. Rheumatol Int. 2019. PMID: 31608418 Review.
Functional outcome was excellent according to patient's capability with daily living activities and specific playing demands. At 12 months follow-up, no recurrences or complications were identified, with the musician returning to his previous level of performance 2 weeks b …
Functional outcome was excellent according to patient's capability with daily living activities and specific playing demands. At 12 month …
[Olmesartan and enteropathy a decade later: a perhaps not so exceptional association].
Albaladejo Blanco C, Martínez Capilla L, Martín García JA. Albaladejo Blanco C, et al. Among authors: martin garcia ja. Hipertens Riesgo Vasc. 2022 Jul-Sep;39(3):128-134. doi: 10.1016/j.hipert.2021.12.002. Epub 2022 Jan 17. Hipertens Riesgo Vasc. 2022. PMID: 35058164 Spanish.
We present the case of a multi-pathological 82-year-old woman with a chronic diarrhoeal syndrome that resulted in a weight loss of 20kg over the last three months. She was prescribed dual therapy for her hypertension: olmesartan 40mg, torasemide 10mg, and lercanidipine 10m …
We present the case of a multi-pathological 82-year-old woman with a chronic diarrhoeal syndrome that resulted in a weight loss of 20kg over …
Effectiveness of sacubitril-valsartan in cancer patients with heart failure.
Martín-Garcia A, López-Fernández T, Mitroi C, Chaparro-Muñoz M, Moliner P, Martin-Garcia AC, Martinez-Monzonis A, Castro A, Lopez-Sendon JL, Sanchez PL. Martín-Garcia A, et al. Among authors: martin garcia ac. ESC Heart Fail. 2020 Apr;7(2):763-767. doi: 10.1002/ehf2.12627. Epub 2020 Feb 5. ESC Heart Fail. 2020. PMID: 32022485 Free PMC article.
Demographic and clinical characteristics and laboratory and echocardiographic data were collected. Median follow-up was 4.6 [1; 11] months. Sixty-seven patients were included (median age was 63 14 years; 64% were female, 87% had at least one cardiovascular risk factor). Me …
Demographic and clinical characteristics and laboratory and echocardiographic data were collected. Median follow-up was 4.6 [1; 11] month …
Platelet-rich plasma in the management of trigger finger: A case report.
Medina-Porqueres I, Martin-Garcia P, Sanz-De-Diego S, Reyes-Eldblom M. Medina-Porqueres I, et al. Among authors: martin garcia p. Agri. 2022 Jul;34(3):222-224. doi: 10.14744/agri.2021.03064. Agri. 2022. PMID: 35792688 Free article.
There was resolution of triggering, with no symptom recurrence at 3-month follow-up. On the basis of this report, we can assume that the treatment of trigger finger with PRP is a promising therapeutic option to be further explored with larger samples and high-quality studi …
There was resolution of triggering, with no symptom recurrence at 3-month follow-up. On the basis of this report, we can assume that …
68 results